Long used by non-diabetic patients as part of preventative therapy for cardiovascular disease, the use of aspirin and diabetes preventative therapies is newer. A scientific statement from 2010 said that low-dose aspirin is “reasonable” for people with no history of vascular disease by with a high 10-year risk of cardiovascular complications. The statement, released by the American Diabetes Association (ADA), American Heart Association (AHA), and American College of Cardiology (ACC) called for stricter criteria in the use of aspirin therapy for diabetics. The new aspirin/diabetes guidelines restrict the once general recommendation of aspirin for diabetics over the age of 40.

Diabetes Aspirin Guidelines

The potential risks of side effects of aspirin therapy have been weighed against the benefits leading to the decision that low-dose aspirin (75-162 mg/d) is now only recommended for diabetic adults with no history of cardiovascular disease but who are at increased risk of cardiovascular …